Tumor progression

MRI Slices - 2007 and 2014 of astrocytoma patient - Steven Keating

Tumor progression refers to the process by which a benign tumor transforms into a malignant cancer. This process involves a series of genetic and epigenetic changes that lead to increased cell proliferation, resistance to apoptosis, and the ability to invade surrounding tissues and metastasize to distant sites.

Stages of Tumor Progression

Tumor progression can be broadly divided into several stages:

Hyperplasia

Hyperplasia is the initial stage where there is an increase in the number of normal cells within a tissue or organ. This stage is characterized by an abnormal proliferation of cells but without significant changes in cell structure or function.

Dysplasia

Dysplasia is a more advanced stage where cells exhibit abnormal growth and morphology. Dysplastic cells show variations in size, shape, and organization, and there is an increased risk of these cells becoming cancerous.

Carcinoma in situ

Carcinoma in situ (CIS) is a stage where cells have acquired some characteristics of cancer but have not yet invaded surrounding tissues. CIS is considered a pre-cancerous condition and has a high potential to progress to invasive cancer if left untreated.

Invasive Cancer

Invasive cancer is the stage where cancer cells break through the basement membrane and invade surrounding tissues. This stage is characterized by the ability of cancer cells to spread to other parts of the body through the bloodstream or lymphatic system.

Metastasis

Metastasis is the final stage of tumor progression where cancer cells spread from the primary tumor site to distant organs and tissues. Metastatic cancer is often more difficult to treat and is associated with a poorer prognosis.

Mechanisms of Tumor Progression

Several mechanisms contribute to tumor progression, including:

Genetic Mutations

Genetic mutations in oncogenes, tumor suppressor genes, and DNA repair genes play a crucial role in tumor progression. These mutations can lead to uncontrolled cell growth and division.

Epigenetic Changes

Epigenetic changes, such as DNA methylation and histone modification, can alter gene expression without changing the DNA sequence. These changes can contribute to the development and progression of cancer.

Tumor Microenvironment

The tumor microenvironment consists of various cell types, signaling molecules, and extracellular matrix components that interact with cancer cells. The microenvironment can influence tumor progression by promoting angiogenesis, immune evasion, and metastasis.

Angiogenesis

Angiogenesis is the process of new blood vessel formation. Tumors stimulate angiogenesis to supply the growing tumor with oxygen and nutrients, which is essential for tumor growth and metastasis.

Immune Evasion

Cancer cells can evade the immune system through various mechanisms, such as downregulating antigen presentation and secreting immunosuppressive factors. Immune evasion allows cancer cells to survive and proliferate despite the body's immune defenses.

Diagnosis and Treatment

The diagnosis of tumor progression involves various techniques, including biopsy, imaging studies, and molecular testing. Treatment options depend on the stage and type of cancer and may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.

See Also

• Cancer
• Oncogene
• Tumor suppressor gene
• Metastasis
• Angiogenesis
• Carcinogenesis

External Links

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian